Matthew C. Garrett Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew C. Garrett.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew C. Garrett. Matthew C. Garrett is a Chief Financial Officer in iRhythm Technologies, Inc. ($IRTC).

Address: C/O IRHYTHM TECHNOLOGIES, INC. 650 TOWNSEND STREET, SUITE 380 SAN FRANCISCO 94103 CA

Companies in which Matthew C. Garrett is an Insider

iRhythm Technologies, Inc.

Trading Symbol: IRTC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Matthew C. Garrett: Chief Financial Officer
Holdings: 24,254 shares
Current Value: $836,763
Latest Transaction: Mar 03 2020
$IRTC Market Capitalization: $801.40M
$IRTC Previous Close: $34.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Matthew C. Garrett

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 03 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...Payment of ExerciseF86.972,961257,51824,25427.2 K to 24.3 K (-10.88 %)
Feb 27 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...GrantA0.006,348027,21520.9 K to 27.2 K (+30.42 %)
Jan 17 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...Option ExerciseM17.0021,013357,2219,585
Jan 17 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...Option ExerciseM8.187,68462,8555,424
Jan 17 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...SellS80.0021,0131,681,04020,86741.9 K to 20.9 K (-50.17 %)
Jan 17 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...SellS80.007,684614,72041,88049.6 K to 41.9 K (-15.50 %)
Jan 17 2020IRTCiRhythm Technologi ...Garrett Matthew C.Chief Financial Off ...BuyM17.0021,013357,22149,56428.6 K to 49.6 K (+73.60 %)

View all Matthew C. Garrett insider transactions.